| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.35 | 0.08 |